MELBOURNE: Medical Developments International Limited (MVP) announced the appointment of Brent MacGregor as Chief Executive Officer of the Company from 1 November 2020.
Brent joined Seqirus in 2015 as Senior Vice President for Commercial Operations reporting directly to Gordon Naylor (see separate ASX release). Seqirus was formed that year from CSL’s acquisition of the Novartis influenza vaccines business and combining it with their own bioCSL operation.
Seqirus had a turnover of circa 700m and was loss making. Seqirus by 2019 had a turnover of 1.2b turnover and EBIT of circa 150m. Brent was at the forefront of the company’s globalisation, focused R&D and rigorous cost management.
Prior to Seqirus, Brent held a number of senior executive roles at Novartis, including CEO of the Novartis influenza vaccine business, President of Novartis Vaccines (U.S.) and Head of North America.
Brent joined Novartis in 2012 from Sanofi Pasteur, where he had a 16-year career. He also held a number of senior leadership roles, including Managing Director, Japan; Managing Director of Australia and New Zealand; Vice President of the Influenza/Pneumococcal Franchise and Executive Director of Global Strategic Planning.
Brent said, “I have token some time to do my due diligence and am very excited about the opportunities for MVP to capitalise on its global registration footprint. In Europe, the taking back of the business from Mundipharma is a big start in doing this. The breadth of MVP in Respiratory, Advanced manufacturing as well as its iconic Penthrox ‘green whistle’ see it very well positioned for growth well into the future. My family are also looking forward to coming back again to live in Australia.”
The Chairman of MVP, David Williams said, “Brent’s role in the growth and globilisation of Seqirus, and his international experience are exactly the skillset we need to drive the next phase of MVP’s growth. It is a bonus that he has lived and worked in Australia before, and worked for an Australian company. We are very comfortable with his drive, his passion and the cultural fit.”
MVP is an Australian company delivering emergency medical solutions dedicated to improving patient outcomes. MVP is a leader in emergency pain relief and respiratory products.
